Details of the Drug
General Information of Drug (ID: DMAI1HU)
Drug Name |
(S)-phenylglycine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2935-35-5; H-Phg-Oh; L-Phenylglycine; (S)-2-Amino-2-phenylacetic acid; L-(+)-alpha-Phenylglycine; L-2-Phenylglycine; (2S)-amino(phenyl)acetic acid; L-(+)-2-Phenylglycine; Phenylglycine; (2S)-2-amino-2-phenylacetic acid; L-(+)-alpha-Aminophenylacetic acid; UNII-3I753R0XI6; L-alpha-Phenylglycine; L(+)-alpha-Phenylglycine; (S)-(+)-2-Phenylglycine; CHEMBL378605; (2S)-amino(phenyl)ethanoic acid; CHEBI:439819; 3I753R0XI6; MFCD00064403; (alphaS)-alpha-aminobenzeneacetic acid
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 151.16 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -1.7 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||||||||